Global analysis of lysine acetylome reveals the potential role of CCL18 in non‐small cell lung cancer
- 11 February 2021
- journal article
- research article
- Published by Wiley in Proteomics
- Vol. 21 (7-8) , 2000144
Abstract
C‐C motif chemokine 18 (CCL18) belongs to the chemokine CC family and is predominantly secreted by M2‐tumor‐associated macrophages. It has been reported to be associated with various diseases and malignancies. Previous studies showed that CCL18 promotes metastasis by activating downstream kinases. However, it remains unknown whether CCL18 regulates post‐translational modifications, other than phosphorylation, during tumorigenesis. Here, we demonstrate that CCL18 is up‐regulated in non‐small cell lung cancer (NSCLC) and is involved in regulating the lysine acetylome in A549 cells. Using the combination of SILAC labeling and high‐efficiency acetylation enrichment methods, we identified 1372 lysine acetylation (Kac) sites on 796 proteins in CCL18‐treated A549 cells. Among the identified Kac sites, 147 from 126 proteins were down‐regulated and seven from five proteins were up‐regulated with fold changes more than two and the p‐value less than 0.05. Bioinformatics analysis further showed that the proteins with down‐regulated acetylation play critical roles in glycolysis, oxidative phosphorylation, tricarboxylic acid cycle, and pentose phosphate pathway in A549 cells. These results suggest that CCL18 may be involved in the development of NSCLC by regulating acetylation of the proteins in many fundamental cellular processes, especially the metabolic reprogramming of tumor cells.Keywords
Funding Information
- National Natural Science Foundation of China (81972184, 81572283, 81972641)
This publication has 43 references indexed in Scilit:
- CCL18 in serum, BAL fluid and alveolar macrophage culture supernatant in interstitial lung diseasesRespiratory Medicine, 2013
- CC-Chemokine Ligand 18 Induces Epithelial to Mesenchymal Transition in Lung Cancer A549 Cells and Elevates the Invasive PotentialPLOS ONE, 2013
- Serum Level of CC-Chemokine Ligand 18 Is Increased in Patients with Non-Small-Cell Lung Cancer and Correlates with Survival Time in AdenocarcinomasPLOS ONE, 2012
- CCL18 in a Multiplex Urine-Based Assay for the Detection of Bladder CancerPLOS ONE, 2012
- Chemokines in tumor development and progressionExperimental Cell Research, 2012
- Evaluation of Proteomics-Identified CCL18 and CXCL1 as Circulating Tumor Markers for Differential Diagnosis between Ovarian Carcinomas and Benign Pelvic MassesThe International Journal of Biological Markers, 2011
- Serum PARC/CCL-18 Concentrations and Health Outcomes in Chronic Obstructive Pulmonary DiseaseAmerican Journal of Respiratory and Critical Care Medicine, 2011
- CCL18 from Tumor-Associated Macrophages Promotes Breast Cancer Metastasis via PITPNM3Cancer Cell, 2011
- Regulation of Cellular Metabolism by Protein Lysine AcetylationScience, 2010
- Involvement of CC chemokine ligand 18 (CCL18) in normal and pathological processesJournal of Leukocyte Biology, 2005